These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11966495)

  • 21. Lansoprazole in children: pharmacokinetics and efficacy in reflux oesophagitis.
    Faure C; Michaud L; Shaghaghi EK; Popon M; Laurence M; Mougenot JF; Hankard R; Navarro J; Jacoz-Aigrain E
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1397-402. PubMed ID: 11552911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole.
    Mee AS; Rowley JL
    Aliment Pharmacol Ther; 1996 Oct; 10(5):757-63. PubMed ID: 8899084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole.
    Hatlebakk JG; Berstad A
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1093-9. PubMed ID: 9663835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus.
    Ouatu-Lascar R; Triadafilopoulos G
    Am J Gastroenterol; 1998 May; 93(5):711-6. PubMed ID: 9625114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
    Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease.
    Stolte M; Meining A; Schmitz JM; Alexandridis T; Seifert E
    Aliment Pharmacol Ther; 1998 Mar; 12(3):247-53. PubMed ID: 9570259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lansoprazole: in the treatment of gastro-oesophageal reflux disease in children and adolescents.
    Croom KF; Scott LJ
    Drugs; 2005; 65(15):2129-35; discussion 2136-7. PubMed ID: 16225368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest pain.
    Xia HH; Lai KC; Lam SK; Hu WH; Wong NY; Hui WM; Lau CP; Chen WH; Chan CK; Wong WM; Wong BC
    Aliment Pharmacol Ther; 2003 Feb; 17(3):369-77. PubMed ID: 12562449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease.
    Castell D; Bagin R; Goldlust B; Major J; Hepburn B
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1467-74. PubMed ID: 15948814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of hiatal hernia on proximal oesophageal acid clearance in gastro-oesophageal reflux disease patients.
    Emerenziani S; Habib FI; Ribolsi M; Caviglia R; Guarino MP; Petitti T; Cicala M
    Aliment Pharmacol Ther; 2006 Mar; 23(6):751-7. PubMed ID: 16556177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole.
    Baldi F; Cappiello R; Cavoli C; Ghersi S; Torresan F; Roda E
    World J Gastroenterol; 2006 Jan; 12(1):82-8. PubMed ID: 16440422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Esomeprazole: a review of its use in the management of acid-related disorders in the US.
    Scott LJ; Dunn CJ; Mallarkey G; Sharpe M
    Drugs; 2002; 62(7):1091-118. PubMed ID: 11985491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On-demand PPI requirements in patients with endoscopy-negative GERD.
    Juul-Hansen P; Rydning A
    J Clin Gastroenterol; 2004 Oct; 38(9):746-9. PubMed ID: 15365398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy-a prospective, randomized, multi-centre study.
    Fass R; Murthy U; Hayden CW; Malagon IB; Pulliam G; Wendel C; Kovacs TO
    Aliment Pharmacol Ther; 2000 Dec; 14(12):1595-603. PubMed ID: 11121907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent acid reflux and symptoms in patients with Barrett's oesophagus on proton-pump inhibitor therapy.
    Basu KK; Bale R; West KP; de Caestecker JS
    Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1187-92. PubMed ID: 12439112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of long-term treatment with proton pump inhibitors in gastro-oesophageal reflux disease on the histological findings in the lower oesophagus.
    Stolte M; Vieth M; Schmitz JM; Alexandridis T; Seifert E
    Scand J Gastroenterol; 2000 Nov; 35(11):1125-30. PubMed ID: 11145281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maximal acid reflux control for Barrett's oesophagus: feasible and effective.
    Srinivasan R; Katz PO; Ramakrishnan A; Katzka DA; Vela MF; Castell DO
    Aliment Pharmacol Ther; 2001 Apr; 15(4):519-24. PubMed ID: 11284781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of lansoprazole in the treatment of gastroesophageal reflux disease in children.
    Tolia V; Ferry G; Gunasekaran T; Huang B; Keith R; Book L
    J Pediatr Gastroenterol Nutr; 2002; 35 Suppl 4():S308-18. PubMed ID: 12607791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of lansoprazole in the treatment of gastroesophageal reflux disease in children.
    Tolia V; Fitzgerald J; Hassall E; Huang B; Pilmer B; Kane R
    J Pediatr Gastroenterol Nutr; 2002; 35 Suppl 4():S300-7. PubMed ID: 12607790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.